CGT

554개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved554 programs
CGTLimited DatastalePediatric Brain Tumor ConsortiumPhase 1

oncolytic HSV-1716 (oncolytic HSV-1716)

Recurrent Childhood Anaplastic Astrocytoma; Recurrent Childhood Anaplastic Oligoastrocytoma · Recurrent Childhood Anaplastic Astrocyto

#RecurrentChildhoodAnaplasticAstr#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Discontinued
CGTLimited DatastaleBaylor College of MedicinePhase 1

21.15.GPC3-CAR T cells (21.15.GPC3-CAR T cells)

Hepatoblastoma; Hepatocellular Carcinoma · Hepatoblastoma

#Hepatoblastoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTAAVLimited DatastaleAdrenas Therapeutics IncPhase 2

AAV BBP-631 (AAV BBP-631)

Congenital Adrenal Hyperplasia · Congenital Adrenal Hyperplasia

#CongenitalAdrenalHyperplasia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTLimited DatastaleAstraZenecaPreclinical

AZD0754 (AZD0754)

Hepatocellular Carcinoma; Prostate Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

AML (Acute Myeloid Leukemia); BPDCN (Blastic Plasmacytoid Dendritic Cell Neoplasm) · AML (Acute Myeloid Leukemia)

#AMLAcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleUTC Therapeutics Inc.Phase 1

Anti-CD70 CAR-T cells (Anti-CD70 CAR-T cells)

Renal Cell Carcinoma · CD70-positive Advanced Urologic Neoplasm

#CD70-positiveAdvancedUrologicNeo#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Discontinued
CGTLimited DatastaleOhio State University Comprehen…Phase 1

Autologous Anti-CD19/CD20/CD22 CAR T-cells (Autologous Anti-CD19/CD20/CD22 CAR T-cells)

Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive; Recurrent Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 2Status Recruiting
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CD19/CD22 Chimeric Antigen Receptor T-cells (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

CD19 Positive; CD22 Positive · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Discontinued
CGTLimited DatastaleJuno Therapeutics, Inc., a Bris…Phase 1

Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes (Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes)

Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent B-Cell Non-Hodgkin Lymphoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Discontinued
CGTLimited DatastaleRobbie MajznerPhase 1

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

Central Nervous System Neoplasms; Brain Tumor · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleChulalongkorn UniversityPhase 1

B7H3 specific CAR T cell with IL-7Ra signaling domain (B7H3 specific CAR T cell with IL-7Ra signaling domain)

DIPG Brain Tumor; Diffuse Intrinsic Pontine Glioma · DIPG Brain Tumor

#DIPGBrainTumor#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleBioray LaboratoriesPhase 2

BCMA-CART (BCMA-CART)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Discontinued
CGTLimited DatastaleNeoImmuneTechPhase 1

CAR T-cell therapy (CAR T-cell therapy)

Large B-cell Lymphoma · Large B-cell Lymphoma

#LargeB-cellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Active
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

CAR-T cells Infusion chimeric antigen receptor T cells (CAR-T cells Infusion chimeric antigen receptor T cells)

Plasma Cell Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleThe Beijing Pregene Science and…Phase 2

CART-19 cells (CART-19 cells)

B-cell Acute Lymphoblastic Leukemia · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Active
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD19-BAFF Targeted CAR T-cells (CD19-BAFF Targeted CAR T-cells)

Acute Lymphoblastic Leukemia,B-Cell; Non-hodgkin Lymphoma,B Cell · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 2Status Recruiting
CGTLimited DatastaleOneChain ImmunotherapeuticsPhase 1

CD1a-CAR T (CD1a-CAR T)

T-cell Acute Lymphoblastic Leukemia; Lymphoblastic T-Cell Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleGyala TherapeuticsPhase 1

CD84-CART (CD84-CART)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleFrontiergate Biopharm（Hainan） C…Phase 1

Claudin18.2-targeted CAR-DCs (Claudin18.2-targeted CAR-DCs)

Colorectal Neoplasia · Colorectal Neoplasia

#ColorectalNeoplasia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTLimited DatastaleHan weidongPhase 2

Decitabine-primed Tandem CAR19/20 engineered T cells (Decitabine-primed Tandem CAR19/20 engineered T cells)

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting

8 / 28 pages

← PreviousNext →